Efficacy and Safety of Pemafibrate Extended-Release Tablet: a Phase 3, Multicenter, Randomized, Double-Blind, Active-Controlled, Parallel-Group Comparison Trial
Journal of Atherosclerosis and Thrombosis · 2024
DOI: 10.5551/jat.64677 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Atherosclerosis and Thrombosis, 2024. Verfasst von Hidenori Arai und 8 weiteren Autor:innen. Beteiligte Einrichtung: National Center for Geriatrics and Gerontology. Hauptthemen laut MEDLINE: Benzoxazoles, Delayed-Action Preparations, Hypertriglyceridemia, Triglycerides. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Center for Geriatrics and Gerontology.
- Rinku General Medical Center.
- Kikuchi Medical Association Hospital.
- Research Center for Health and Sports Sciences, Kumamoto Health Science University.
- Department of Endocrinology, Hematology and Gerontology, Chiba University Graduate School of Medicine.
- Global Clinical Development Department, Kowa Company, Ltd.
Zitieren
APA
Arai, H., Yamashita, S., Araki, E., Yokote, K., Tanigawa, R., Saito, A., Yamasaki, S., Suganami, H., & Ishibashi, S. (2024). Efficacy and Safety of Pemafibrate Extended-Release Tablet: a Phase 3, Multicenter, Randomized, Double-Blind, Active-Controlled, Parallel-Group Comparison Trial. Journal of Atherosclerosis and Thrombosis. https://doi.org/10.5551/jat.64677
Vancouver
Arai H, Yamashita S, Araki E, Yokote K, Tanigawa R, Saito A, et al. Efficacy and Safety of Pemafibrate Extended-Release Tablet: a Phase 3, Multicenter, Randomized, Double-Blind, Active-Controlled, Parallel-Group Comparison Trial. Journal of Atherosclerosis and Thrombosis. 2024. doi:10.5551/jat.64677
BibTeX
@article{Arai2024,
author = {Arai, Hidenori and Yamashita, Shizuya and Araki, Eiichi and Yokote, Koutaro and Tanigawa, Ryohei and Saito, Ayumi and Yamasaki, Sayumi and Suganami, Hideki and Ishibashi, Shun},
title = {Efficacy and Safety of Pemafibrate Extended-Release Tablet: a Phase 3, Multicenter, Randomized, Double-Blind, Active-Controlled, Parallel-Group Comparison Trial},
journal = {Journal of Atherosclerosis and Thrombosis},
year = {2024},
doi = {10.5551/jat.64677}
}
EUVIMED